Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Frye

Showing results (461-470 of 519) with videos related to

Pageof 52
Sort By:
Bipolar Disorders|September 12, 2025
A Cross-Sectional Analysis of Social Determinants of Health in Bipolar Disorder: Exploring Gender-Related DifferencesManuel Gardea-Resendez, Manuel Fuentes-Salgado, Francisco Romo-Nava, et al.
Journal of Affective Disorders|May 16, 2026
Accelerated biological aging in bipolar disorder as determined by artificial intelligence-based electrocardiographic assessmentAlessandro Miola, Betsy J Medina-Inojosa, Alfredo B Cuellar-Barboza, et al.
Journal of Affective Disorders|October 10, 2025
Acid accumulation in bipolar disorderAndres Marcelo Trevino-Alvarez, Vanessa Pazdernik, Manuel Gardea-Resendez, et al.
Journal of Affective Disorders|December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depressionSagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.
The Journal of Clinical Investigation|January 8, 2026
Alcohol use disorder-associated gene FNDC4 alters glutamatergic and GABAergic neurogenesis in neural organoidsXiujuan Zhu, August J John, Sooan Kim, et al.
Biological Psychiatry Global Open Science|June 12, 2025
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant DepressionStephen A Murata, Zachary B Madaj, Colt D Capan, et al.
Journal of Affective Disorders|February 15, 2020
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesAhmed T Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
Translational Psychiatry|January 11, 2018
Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomicsDuan Liu, Balmiki Ray, Drew R Neavin, et al.
Molecular Psychiatry|March 6, 2021
Circadian rhythms in bipolar disorder patient-derived neurons predict lithium response: preliminary studiesHimanshu K Mishra, Noelle M Ying, Angelica Luis, et al.
Translational Psychiatry|February 13, 2024
Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorderNicolas A Nuñez, Brandon J Coombes, Lindsay Melhuish Beaupre, et al.
Pageof 52

Showing results (461-470 of 519) with videos related to

Sort By:
Pageof 52
Bipolar Disorders|September 12, 2025
A Cross-Sectional Analysis of Social Determinants of Health in Bipolar Disorder: Exploring Gender-Related DifferencesManuel Gardea-Resendez, Manuel Fuentes-Salgado, Francisco Romo-Nava, et al.
Journal of Affective Disorders|May 16, 2026
Accelerated biological aging in bipolar disorder as determined by artificial intelligence-based electrocardiographic assessmentAlessandro Miola, Betsy J Medina-Inojosa, Alfredo B Cuellar-Barboza, et al.
Journal of Affective Disorders|October 10, 2025
Acid accumulation in bipolar disorderAndres Marcelo Trevino-Alvarez, Vanessa Pazdernik, Manuel Gardea-Resendez, et al.
Journal of Affective Disorders|December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depressionSagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.
The Journal of Clinical Investigation|January 8, 2026
Alcohol use disorder-associated gene FNDC4 alters glutamatergic and GABAergic neurogenesis in neural organoidsXiujuan Zhu, August J John, Sooan Kim, et al.
Biological Psychiatry Global Open Science|June 12, 2025
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant DepressionStephen A Murata, Zachary B Madaj, Colt D Capan, et al.
Journal of Affective Disorders|February 15, 2020
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesAhmed T Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
Translational Psychiatry|January 11, 2018
Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomicsDuan Liu, Balmiki Ray, Drew R Neavin, et al.
Molecular Psychiatry|March 6, 2021
Circadian rhythms in bipolar disorder patient-derived neurons predict lithium response: preliminary studiesHimanshu K Mishra, Noelle M Ying, Angelica Luis, et al.
Translational Psychiatry|February 13, 2024
Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorderNicolas A Nuñez, Brandon J Coombes, Lindsay Melhuish Beaupre, et al.
Pageof 52